Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1379321

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1379321

Immunochemicals Market by Product (Antibodies, Cytokines & Chemokines, Immunoglobulins), Source (Animal-Derived, Synthetic), Application, End-User - Global Forecast 2023-2030

PUBLISHED:
PAGES: 184 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & Online Access - 1 Year (Single User License)
USD 4749
PDF, Excel & Online Access - 1 Year (Up to 5 User License)
USD 5749
PDF, Excel & Online Access - 1 Year (Site License)
USD 6749
PDF, Excel & Online Access - 1 Year (Enterprise User License)
USD 8749

Add to Cart

The Immunochemicals Market is projected to reach USD 4.75 billion by 2030 from USD 2.73 billion in 2022, at a CAGR of 7.14% during the forecast period.

Global Immunochemicals Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 2.73 billion
Estimated Year Value [2023] USD 2.92 billion
Forecast Year Value [2030] USD 4.75 billion
CAGR (%) 7.14%
Immunochemicals Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Immunochemicals Market.

Based on Product, market is studied across Antibodies, Cytokines & Chemokines, and Immunoglobulins. The Cytokines & Chemokines is projected to witness significant market share during forecast period.

Based on Source, market is studied across Animal-Derived and Synthetic. The Animal-Derived is projected to witness significant market share during forecast period.

Based on Application, market is studied across Autoimmune Disease, Infectious Disease, Neurology, and Oncology. The Oncology is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Contract Research Organizations, Forensic Organizations, and Research & Academic Institutes. The Biotechnology & Pharmaceutical Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Immunochemicals Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Immunochemicals Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Immunochemicals Market, highlighting leading vendors and their innovative profiles. These include Abbiotec, Inc., Abcam PLC, Active Motif Incorporated, Agilent Technologies, Inc., AMS Biotechnology (Europe) Limited., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biocare Medical, LLC, BioGenex Laboratories, Biosynth Laboratories, BMA Biomedicals, Cayman Chemical, Cell Signaling Technology, Inc., Creative Diagnostics, Danahar Corporation, Elabscience Biotechnology Inc., F. Hoffmann-La Roche Ltd, Fortis Life Sciences, GE Healthcare, Genemed Biotechnologies, Inc., GenScript Biotech Corporation, Merck KGaA, Miltenyi Biotech, MyBioSource, Origene Technologies Inc., PerkinElmer, Inc., Rockland Immunochemicals, Inc., Santa Cruz Biotechnology, Specifica Inc., and Thermo Fisher Scientific Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Immunochemicals Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Immunochemicals Market?

3. What is the competitive strategic window for identifying opportunities in the Immunochemicals Market?

4. What are the latest technology trends and regulatory frameworks in the Immunochemicals Market?

5. What is the market share of the leading vendors in the Immunochemicals Market?

6. Which modes and strategic moves are suitable for entering the Immunochemicals Market?

Product Code: MRR-C002B1C99526

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Immunochemicals Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing drug discovery and development activities worldwide
      • 5.1.1.2. Government support for immunochemistry, genomics, and proteomics research
      • 5.1.1.3. Use of immunochemical techniques for early disease detection and diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. Risk of cross-contamination and possibilities of false positives in test kits
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise of advanced formulations of immunochemical for research
      • 5.1.3.2. Adoption of nanotechnology to develop advanced clinical diagnostic test kits
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory guidelines regarding the production and use of immunochemical
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Immunochemicals Market, by Product

  • 6.1. Introduction
  • 6.2. Antibodies
  • 6.3. Cytokines & Chemokines
  • 6.4. Immunoglobulins

7. Immunochemicals Market, by Source

  • 7.1. Introduction
  • 7.2. Animal-Derived
  • 7.3. Synthetic

8. Immunochemicals Market, by Application

  • 8.1. Introduction
  • 8.2. Autoimmune Disease
  • 8.3. Infectious Disease
  • 8.4. Neurology
  • 8.5. Oncology

9. Immunochemicals Market, by End-User

  • 9.1. Introduction
  • 9.2. Biotechnology & Pharmaceutical Companies
  • 9.3. Clinical Laboratories
  • 9.4. Contract Research Organizations
  • 9.5. Forensic Organizations
  • 9.6. Research & Academic Institutes

10. Americas Immunochemicals Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Immunochemicals Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Immunochemicals Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbiotec, Inc.
    • 14.1.2. Abcam PLC
    • 14.1.3. Active Motif Incorporated
    • 14.1.4. Agilent Technologies, Inc.
    • 14.1.5. AMS Biotechnology (Europe) Limited.
    • 14.1.6. Becton, Dickinson and Company
    • 14.1.7. Bio-Rad Laboratories, Inc.
    • 14.1.8. Bio-Techne Corporation
    • 14.1.9. Biocare Medical, LLC
    • 14.1.10. BioGenex Laboratories
    • 14.1.11. Biosynth Laboratories
    • 14.1.12. BMA Biomedicals
    • 14.1.13. Cayman Chemical
    • 14.1.14. Cell Signaling Technology, Inc.
    • 14.1.15. Creative Diagnostics
    • 14.1.16. Danahar Corporation
    • 14.1.17. Elabscience Biotechnology Inc.
    • 14.1.18. F. Hoffmann-La Roche Ltd
    • 14.1.19. Fortis Life Sciences
    • 14.1.20. GE Healthcare
    • 14.1.21. Genemed Biotechnologies, Inc.
    • 14.1.22. GenScript Biotech Corporation
    • 14.1.23. Merck KGaA
    • 14.1.24. Miltenyi Biotech
    • 14.1.25. MyBioSource
    • 14.1.26. Origene Technologies Inc.
    • 14.1.27. PerkinElmer, Inc.
    • 14.1.28. Rockland Immunochemicals, Inc.
    • 14.1.29. Santa Cruz Biotechnology
    • 14.1.30. Specifica Inc.
    • 14.1.31. Thermo Fisher Scientific Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
Product Code: MRR-C002B1C99526

LIST OF FIGURES

  • FIGURE 1. IMMUNOCHEMICALS MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOCHEMICALS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. IMMUNOCHEMICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. IMMUNOCHEMICALS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. IMMUNOCHEMICALS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. IMMUNOCHEMICALS MARKET DYNAMICS
  • FIGURE 7. IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
  • FIGURE 10. IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 12. IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 14. IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. IMMUNOCHEMICALS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. IMMUNOCHEMICALS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. IMMUNOCHEMICALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. IMMUNOCHEMICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. IMMUNOCHEMICALS MARKET SIZE, BY CYTOKINES & CHEMOKINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. IMMUNOCHEMICALS MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 10. IMMUNOCHEMICALS MARKET SIZE, BY ANIMAL-DERIVED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. IMMUNOCHEMICALS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. IMMUNOCHEMICALS MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. IMMUNOCHEMICALS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. IMMUNOCHEMICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. IMMUNOCHEMICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. IMMUNOCHEMICALS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. IMMUNOCHEMICALS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. IMMUNOCHEMICALS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. IMMUNOCHEMICALS MARKET SIZE, BY FORENSIC ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. IMMUNOCHEMICALS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. IMMUNOCHEMICALS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 192. IMMUNOCHEMICALS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 193. IMMUNOCHEMICALS MARKET LICENSE & PRICING
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!